3-maleimidobenzoyl n-hydroxysuccinimide has been researched along with Multiple Myeloma in 1 studies
*Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomita, M; Tsong, TY | 1 |
1 other study(ies) available for 3-maleimidobenzoyl n-hydroxysuccinimide and Multiple Myeloma
| Article | Year |
|---|---|
Selective production of hybridoma cells: antigenic-based pre-selection of B lymphocytes for electrofusion with myeloma cells.
Topics: Animals; Antigens; Avidin; B-Lymphocytes; Biotin; Cell Fusion; Cell Separation; Cross-Linking Reagents; Electricity; Hybridomas; Mice; Multiple Myeloma; Succinimides; Tumor Cells, Cultured | 1990 |